Lionheart Health to Showcase Regenerative Technology at Prestigious Medical Innovation Forum
Lionheart Health's upcoming presentation at the Octane Medical Innovation Forum highlights the company's groundbreaking work in organ regeneration and healthspan longevity technologies, signaling significant advancements in the medical aesthetics and aging management industries.
Lionheart Health, Inc., operator of Lionheart Longevity & Wellness Clinics, will present its innovative technology platform at the 2025 Octane Medical Innovation Forum scheduled for October 28-29 in Irvine, California. The forum, which focuses on The Science of Longevity, brings together industry experts, entrepreneurs, investors and thought leaders for two days of learning and innovation. More information about the event can be found at https://www.octane-oc.org/event/omif/agenda.
Executive Chairman and co-CEO Howard Leonhardt will showcase the company's first-in-class technology platform that utilizes precise patented bioelectric signaling sequences to trigger the release of regeneration-promoting proteins. This technology enables controlled expression of klotho, a protein identified as crucial for aging management, and regulates stem cell recruitment, proliferation and differentiation on demand. The platform represents a significant advancement in regenerative medicine with potential implications for extending human healthspan.
The company's business model involves licensing its patented technology to clinics worldwide through exclusive territory agreements. Currently operating one clinic in Newport Beach, California, with seven additional licensed locations, Lionheart Health aims to expand to 124 licensed sites within the next five years. This aggressive expansion strategy underscores the growing market demand for regenerative aesthetics and longevity technologies.
Lionheart Health's recent recognitions validate the significance of its technological innovations. The company was named a top 40 semi-finalist in the XPRIZE Healthspan Competition among 600 entries, focusing on improvements in muscle health, brain health and immunity health with the goal of increasing healthy living years by two decades. Additional accolades include winning Medtech Outlook Magazine's Top Micro Stimulator Implant Development of 2025 award and being a finalist in both the Orange County Business Journal's Innovator of the Year Award and the Octane High Tech Awards' Medical Innovation category.
The company's most ambitious project involves developing a whole body regeneration chamber, described as a womb for adults. Current prototypes utilize non-invasive technologies, with future versions planned to incorporate advanced robotics, artificial intelligence, and implantable pump and stimulation technologies for internal organ regeneration. This project represents a paradigm shift in regenerative medicine approaches.
Recent strategic partnerships include a collaboration with CoreViva for AI-enhanced MRI diagnostics, demonstrating Lionheart Health's commitment to integrating cutting-edge technologies into its platform. The company maintains strong academic ties as a long-standing lab resident of University Lab Partners and the UCI Beall Applied Innovation Center Prototyping Lab, having received multiple UCI Capstone Grants for its Brain Band bioelectric stimulation technology for brain health.
The upcoming presentation at the Octane Medical Innovation Forum provides Lionheart Health with a platform to demonstrate how its technologies could transform approaches to aging and regenerative medicine. The company's focus on practical applications of longevity science positions it at the forefront of an emerging industry focused on extending human healthspan through innovative medical technologies.